Manulife (Manufacturers Life Insurance)’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $81.7M | Buy |
1,891,578
+3,815
| +0.2% | +$165K | 0.07% | 246 |
|
|
2025
Q1 | $65.3M | Buy |
1,887,763
+1,969
| +0.1% | +$68.1K | 0.06% | 281 |
|
|
2024
Q4 | $51.7M | Buy |
1,885,794
+353,570
| +23% | +$9.7M | 0.04% | 350 |
|
|
2024
Q3 | $39M | Sell |
1,532,224
-2,748
| -0.2% | -$70K | 0.03% | 430 |
|
|
2024
Q2 | $38.9M | Buy |
1,534,972
+442,248
| +40% | +$11.2M | 0.04% | 407 |
|
|
2024
Q1 | $33.8M | Buy |
1,092,724
+348,592
| +47% | +$10.8M | 0.03% | 454 |
|
|
2023
Q4 | $30M | Buy |
744,132
+78,528
| +12% | +$3.17M | 0.02% | 496 |
|
|
2023
Q3 | $17.6M | Buy |
665,604
+419,813
| +171% | +$11.1M | 0.01% | 627 |
|
|
2023
Q2 | $4.23M | Buy |
245,791
+201,481
| +455% | +$3.47M | ﹤0.01% | 1160 |
|
|
2023
Q1 | $735K | Buy |
44,310
+408
| +0.9% | +$6.77K | ﹤0.01% | 1775 |
|
|
2022
Q4 | $335K | Buy |
43,902
+897
| +2% | +$6.84K | ﹤0.01% | 2239 |
|
|
2022
Q3 | $427K | Sell |
43,005
-793
| -2% | -$7.88K | ﹤0.01% | 2077 |
|
|
2022
Q2 | $398K | Sell |
43,798
-1,386
| -3% | -$12.6K | ﹤0.01% | 2199 |
|
|
2022
Q1 | $459K | Sell |
45,184
-9,480
| -17% | -$96.2K | ﹤0.01% | 2258 |
|
|
2021
Q4 | $912 | Sell |
54,664
-1,572
| -3% | -$26 | ﹤0.01% | 1892 |
|
|
2021
Q3 | $2.64M | Sell |
56,236
-5,200
| -8% | -$244K | ﹤0.01% | 1431 |
|
|
2021
Q2 | $3.75M | Buy |
61,436
+6,563
| +12% | +$400K | ﹤0.01% | 1396 |
|
|
2021
Q1 | $3.38M | Buy |
54,873
+10,270
| +23% | +$633K | ﹤0.01% | 1391 |
|
|
2020
Q4 | $3.17M | Buy |
44,603
+1,390
| +3% | +$98.9K | ﹤0.01% | 1388 |
|
|
2020
Q3 | $1.62M | Sell |
43,213
-1,154
| -3% | -$43.3K | ﹤0.01% | 1486 |
|
|
2020
Q2 | $1.45M | Sell |
44,367
-3,235
| -7% | -$105K | ﹤0.01% | 1489 |
|
|
2020
Q1 | $1.38M | Buy |
47,602
+31,594
| +197% | +$916K | ﹤0.01% | 1424 |
|
|
2019
Q4 | $561K | Buy |
16,008
+114
| +0.7% | +$4K | ﹤0.01% | 1985 |
|
|
2019
Q3 | $320K | Buy |
+15,894
| New | +$320K | ﹤0.01% | 2284 |
|